BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29232380)

  • 1. Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab.
    Sun C; Han C; Jiang Y; Han N; Zhang M; Li G; Qiao Q
    PLoS One; 2017; 12(12):e0188932. PubMed ID: 29232380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR confers radioresistance in human oropharyngeal carcinoma by activating endoplasmic reticulum stress signaling PERK-eIF2α-GRP94 and IRE1α-XBP1-GRP78.
    Zhang M; Han N; Jiang Y; Wang J; Li G; Lv X; Li G; Qiao Q
    Cancer Med; 2018 Dec; 7(12):6234-6246. PubMed ID: 30414263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 production mediated by the IRE1-XBP1 pathway confers radioresistance in human papillomavirus-negative oropharyngeal carcinoma.
    Lyu X; Zhang M; Li G; Cai Y; Li G; Qiao Q
    Cancer Sci; 2019 Aug; 110(8):2471-2484. PubMed ID: 31187548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum stress pathway PERK-eIF2α confers radioresistance in oropharyngeal carcinoma by activating NF-κB.
    Qiao Q; Sun C; Han C; Han N; Zhang M; Li G
    Cancer Sci; 2017 Jul; 108(7):1421-1431. PubMed ID: 28418119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures.
    Rossow L; Eke I; Dickreuter E; Cordes N
    Oncol Rep; 2015 Jul; 34(1):469-76. PubMed ID: 26004008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
    Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
    Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
    Gupta AK; McKenna WG; Weber CN; Feldman MD; Goldsmith JD; Mick R; Machtay M; Rosenthal DI; Bakanauskas VJ; Cerniglia GJ; Bernhard EJ; Weber RS; Muschel RJ
    Clin Cancer Res; 2002 Mar; 8(3):885-92. PubMed ID: 11895923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
    Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
    Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.
    Toulany M; Kasten-Pisula U; Brammer I; Wang S; Chen J; Dittmann K; Baumann M; Dikomey E; Rodemann HP
    Clin Cancer Res; 2006 Jul; 12(13):4119-26. PubMed ID: 16818713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of HNSCC cells by 90Y-labeled cetuximab strictly depends on the number of induced DNA double-strand breaks.
    Saker J; Kriegs M; Zenker M; Heldt JM; Eke I; Pietzsch HJ; Grénman R; Cordes N; Petersen C; Baumann M; Steinbach J; Dikomey E; Kasten-Pisula U
    J Nucl Med; 2013 Mar; 54(3):416-23. PubMed ID: 23345302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress.
    Tay KH; Luan Q; Croft A; Jiang CC; Jin L; Zhang XD; Tseng HY
    Cell Signal; 2014 Feb; 26(2):287-94. PubMed ID: 24240056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
    Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
    Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
    Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy.
    Kim EJ; Jeong JH; Bae S; Kang S; Kim CH; Lim YB
    J Cell Biochem; 2013 Jun; 114(6):1248-56. PubMed ID: 23592446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR-inhibition enhances apoptosis in irradiated human head and neck xenograft tumors independent of effects on DNA repair.
    Stegeman H; Span PN; Cockx SC; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH; Bussink J
    Radiat Res; 2013 Oct; 180(4):414-21. PubMed ID: 24059677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining.
    Kriegs M; Kasten-Pisula U; Rieckmann T; Holst K; Saker J; Dahm-Daphi J; Dikomey E
    DNA Repair (Amst); 2010 Aug; 9(8):889-97. PubMed ID: 20615764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signal networks and regulating mechanisms of the unfolded protein response.
    Gong J; Wang XZ; Wang T; Chen JJ; Xie XY; Hu H; Yu F; Liu HL; Jiang XY; Fan HD
    J Zhejiang Univ Sci B; 2017 Jan.; 18(1):1-14. PubMed ID: 28070992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRE1α dissociates with BiP and inhibits ER stress-mediated apoptosis in cartilage development.
    Han X; Zhou J; Zhang P; Song F; Jiang R; Li M; Xia F; Guo FJ
    Cell Signal; 2013 Nov; 25(11):2136-46. PubMed ID: 23816533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming radioresistance in head and neck squamous cell carcinoma.
    Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
    Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.